Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

News Conference News AHA 2017

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

Michael O'Riordan

November 21, 2017

Presentation TCT 2017

Large-hole Trans-femoral Closure III: The PerQseal Device

Presenter: Jeffrey J. Popma

October 31, 2017

Presentation TCT 2017

Large-hole Trans-femoral Closure II: The Inseal Device

Presenter: Ran Kornowski

October 31, 2017

Presentation TCT 2017

Large-hole Trans-femoral Closure I: The Manta Device

Presenter: Nicolas M. Van Mieghem

October 31, 2017

Presentation TCT 2017

Trans-carotid Access for TAVR Is the Preferred Non-femoral Access of Choice

Presenter: Keith B. Allen

October 31, 2017

News Daily News

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Shelley Wood

October 10, 2017

Presentation iASSESS 2017

Femoral Access and Related Complications

Presenter: Arnold Seto

August 30, 2017

News Industry News

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

August 01, 2017

News Daily News

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Michael O'Riordan

June 26, 2017

News Conference News EuroPCR 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Shelley Wood

May 12, 2017

Presentation Miami Valves 2017

Radial vs. Femoral Secondary Access in Trans-catheter Aortic Valve Replacement: The Miami Experience

Presenter: Daniel Miklin

January 29, 2017

News Daily News

Clinical Outcomes With Subclavian TAVR as Good as With Transfemoral Access, Small Analysis Shows

Michael O'Riordan

January 26, 2017

Advertisement

Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I

Large-hole Trans-femoral Closure III: The PerQseal Device

Large-hole Trans-femoral Closure II: The Inseal Device

Large-hole Trans-femoral Closure I: The Manta Device

Trans-carotid Access for TAVR Is the Preferred Non-femoral Access of Choice

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Femoral Access and Related Complications

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Radial vs. Femoral Secondary Access in Trans-catheter Aortic Valve Replacement: The Miami Experience

Clinical Outcomes With Subclavian TAVR as Good as With Transfemoral Access, Small Analysis Shows

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content